Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Danol 100mg Capsules.
| Pharmaceutical Form |
|---|
|
Capsule, hard. Capsule with a grey cap and opaque white body containing a white or almost white powder, with ‘D100’ printed in black ink. |
Each capsule contains 100mg of danazol.
Also contains 62 mg of lactose monohydrate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Danazol |
Danazol is a synthetic steroid derived from ethisterone an is indicated for the treatment of endometriosis and benign fibrocystic breast disease. |
| List of Excipients |
|---|
|
Capsule: Maize starch Cap: Titanium dioxide (E171) Capsule Shell Body (size 3): Titanium dioxide (E171) Black Ink: Shellac Glaze 45% (20% esterified) in ethanol Or Shellac |
PVC blister pack compound of polyvinyl chloride (thickness 250µm) sealed to aluminium foil (thickness 20µm). The blisters are then packed in a cardboard carton.
Pack sizes: 50, 60 and 100 capsules.
Not all pack sizes may be marketed.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0194
Date of First Authorisation: 10 June 1974
Date of Latest Renewal: 2 April 2002
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
